Your browser doesn't support javascript.
loading
Practice Preferences on Dabigatran and Rivaroxaban for Stroke Prevention in Patients with Non-valvular Atrial Fibrillation
Korean Journal of Clinical Pharmacy ; : 207-212, 2016.
Article in English | WPRIM | ID: wpr-62527
ABSTRACT

OBJECTIVE:

Prescription rate of dabigatran and rivaroxaban, which are the direct oral anticoagulants (DOAC), has increased. We have analyzed the prescription trend and medication use of dabigatran and rivaroxaban in patients with non-valvular atrial fibrillation (NVAF).

METHODS:

It was retrospectively studied from September 2012 to April 2014 using the electronic medical records and the progress notes. Patients with NVAF (n=424) were evaluated on the medication use, prescribing preferences, adverse drug reactions (ADRs) and the availability of prescription reimbursement of dabigatran (n=210) and rivaroxaban (n=214).

RESULTS:

Dabigatran was prescribed higher than rivaroxaban (23.3% versus 7.5%, p<0.001) in the neurology department, but rivaroxaban was prescribed higher compared to dabigatran in the cardiology department (87.4% versus 74.3%, p<0.001). Dabigatran was prescribed more than rivaroxaban in high risk patients with CHADS2 score ≥ 3 (44.3% versus 31.3%, p=0.006). Dabigatran patients seemed to have more ADRs than patients with rivaroxaban (25.2% versus 11.2%, p<0.001), but no serious thrombotic events and bleeding were found. Only 35.6% (n=151) were eligible for prescription reimbursement by the National Health Insurance (NHI). Bridging therapy (86, 31.5%) and direct-current cardioversion (57, 20.2%) were main reasons of ineligibility for reimbursement.

CONCLUSION:

Prescription preferences were present in choosing either dabigatran or rivaroxaban for patients with NVAF. Inpatient protocols and procedures considering patient-factors in NVAF need to be developed.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Atrial Fibrillation / Electric Countershock / Cardiology / Retrospective Studies / Stroke / Drug-Related Side Effects and Adverse Reactions / Prescriptions / Electronic Health Records / Rivaroxaban / Dabigatran Type of study: Practice guideline / Observational study Limits: Humans Language: English Journal: Korean Journal of Clinical Pharmacy Year: 2016 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Atrial Fibrillation / Electric Countershock / Cardiology / Retrospective Studies / Stroke / Drug-Related Side Effects and Adverse Reactions / Prescriptions / Electronic Health Records / Rivaroxaban / Dabigatran Type of study: Practice guideline / Observational study Limits: Humans Language: English Journal: Korean Journal of Clinical Pharmacy Year: 2016 Type: Article